Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study
Esther Conde(Universidad Complutense de Madrid), Fernando López‐Ríos(Hospital Universitario 12 De Octubre)
Cited by 71
Related Papers
A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry
|PLoS ONE|2012|107
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
|Clinical & Translational Oncology|2019|104
Molecular diagnosis in non-small-cell lung cancer: expert opinion on <i>ALK</i> and <i>ROS1</i> testing
|Journal of Clinical Pathology|2021|45